After his recent appointment to a national health IT advisory committee, Soon-Shiong explained how his life's work is now converging towards major advances in cancer and healthcare more broadly.
On the phone, Patrick Soon-Shiong speaks slowly and deliberately. He clearly trusts himself, but he doesn't trust journalists anymore.
A series of scathing articles by STAT News and Politico sent stocks in his publicly-traded companies tumbling earlier this year. That narrative may be changed somewhat if data about a cancer vaccine set to be revealed Monday at a major oncology conference is impressive.
